Edition:
India

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

3.00USD
19 Jan 2018
Change (% chg)

$0.55 (+22.45%)
Prev Close
$2.45
Open
$2.49
Day's High
$4.44
Day's Low
$2.47
Volume
836,502
Avg. Vol
45,601
52-wk High
$7.75
52-wk Low
$1.64

Chart for

About

Bioblast Pharma Ltd (BioBlast) is an Israel-based development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $7.39
Shares Outstanding(Mil.): 3.34
Dividend: --
Yield (%): --

Financials

BRIEF-Bioblast Pharma reports Q3 loss per share $0.32

* Bioblast Pharma reports third quarter 2017 financial results

02 Nov 2017

BRIEF-Bioblast announces effectiveness of five to one reverse split

* Bioblast announces effectiveness of five to one reverse split

25 Sep 2017

BRIEF-Bioblast Pharma reports Q2 loss per share $0.10

* Bioblast Pharma reports second quarter 2017 financial results

05 Aug 2017

Earnings vs. Estimates